Page last updated: 2024-10-18

indole and Glioma

indole has been researched along with Glioma in 1 studies

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
" To explore the induction of methuosis as a potential therapeutic strategy for killing cancer cells, we have developed small molecules (indole-based chalcones) that trigger this form of cell death in glioblastoma and other cancer cell lines."7.85Disruption of endolysosomal trafficking pathways in glioma cells by methuosis-inducing indole-based chalcones. ( Maltese, WA; Mbah, NE; Overmeyer, JH, 2017)
" To explore the induction of methuosis as a potential therapeutic strategy for killing cancer cells, we have developed small molecules (indole-based chalcones) that trigger this form of cell death in glioblastoma and other cancer cell lines."3.85Disruption of endolysosomal trafficking pathways in glioma cells by methuosis-inducing indole-based chalcones. ( Maltese, WA; Mbah, NE; Overmeyer, JH, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mbah, NE1
Overmeyer, JH1
Maltese, WA1

Other Studies

1 other study available for indole and Glioma

ArticleYear
Disruption of endolysosomal trafficking pathways in glioma cells by methuosis-inducing indole-based chalcones.
    Cell biology and toxicology, 2017, Volume: 33, Issue:3

    Topics: Amyloid beta-Protein Precursor; Apoptosis; Autophagosomes; Autophagy; Cell Line, Tumor; Cell Surviva

2017